NEURO NEWS
Neurological News with information about conditions, treatments, current studies and breakthroughs.
How TMS Therapy Supports Stroke Rehabilitation: A Path to Recovery
Stroke can have a profound impact on an individual’s life, leading to physical and cognitive impairments. Traditional rehabilitation methods are [...]
Unlocking New Possibilities: TMS Therapy for Anxiety Disorders
Anxiety disorders are among the most common mental health conditions, impacting millions of people worldwide. Traditional treatments often include therapy [...]
Harnessing the Power of TMS Therapy for Depression
Depression affects millions of people globally, often causing a significant impact on daily life. While traditional treatments like medication and [...]
Exploring TMS Therapy for Obsessive-Compulsive Disorder (OCD)
Obsessive-Compulsive Disorder (OCD) can severely impact daily life, characterized by persistent, intrusive thoughts and repetitive behaviors. While traditional treatments like [...]
TMS Therapy for Post-Traumatic Stress Disorder (PTSD): A New Hope
Post-Traumatic Stress Disorder (PTSD) can profoundly affect an individual’s life, leading to symptoms such as flashbacks, severe anxiety, and emotional [...]
Unlocking New Potential: TMS Therapy for Attention Deficit Hyperactivity Disorder (ADHD)
Attention Deficit Hyperactivity Disorder (ADHD) can impact many areas of life, including concentration, impulse control, and organization. While traditional treatments [...]
- Medicinal Signaling Cell Therapy Fast Tracked for Mild Alzheimer Disease July 29, 2024The investigational allogeneic cellular therapy is believed to impart anti-inflammatory, pro-vascular, and pro-regenerative effects.
- Endo Recalls Clonazepam ODT Due to Carton Label Displaying Incorrect Strength July 29, 2024The product is being recalled because the incorrect strength of 0.125mg is appearing on the carton labels.
- Investigational Gene Therapy for Parkinson Disease Gets Fast Track Status July 22, 2024AB-1005 is an investigational gene therapy based on AAV2 containing the human GDNF transgene.
- FDA Approves Aflibercept Biosimilar Ahzantive July 16, 2024Ahzantive is a vascular endothelial growth factor inhibitor.
- Ketamine May Reduce Cluster Headache Symptoms July 2, 2024Researchers sought to evaluate ketamine as a potentially promising treatment approach.
Get Social